Annual Shareholders Equity
$82.55 M
-$24.91 M-23.18%
December 31, 2023
Summary
- As of February 6, 2025, TRVI annual stockholders equity is $82.55 million, with the most recent change of -$24.91 million (-23.18%) on December 31, 2023.
- During the last 3 years, TRVI annual shareholders equity has risen by +$55.27 million (+202.57%).
- TRVI annual shareholders equity is now -23.18% below its all-time high of $107.46 million, reached on December 31, 2022.
Performance
TRVI Shareholders Equity Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Highlights
High & Low
Earnings dates
Quarterly Shareholders Equity
$58.97 M
-$7.21 M-10.89%
September 30, 2024
Summary
- As of February 6, 2025, TRVI quarterly stockholders equity is $58.97 million, with the most recent change of -$7.21 million (-10.89%) on September 30, 2024.
- Over the past year, TRVI quarterly shareholders equity has dropped by -$23.58 million (-28.56%).
- TRVI quarterly shareholders equity is now -46.34% below its all-time high of $109.90 million, reached on September 30, 2022.
Performance
TRVI Quarterly Shareholders Equity Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Highlights
High & Low
Earnings dates
Shareholders Equity Formula
Shareholders Equity = Total Assets − Total Liabilities
TRVI Shareholders Equity Trends
| PeriodPeriod | AnnualAnnual | QuarterlyQuarterly |
|---|---|---|
| 1 y1 year | -23.2% | -28.6% |
| 3 y3 years | +202.6% | +418.2% |
| 5 y5 years | +1221.2% | -2.9% |
TRVI Shareholders Equity Highs & Lows
| PeriodPeriod | Annual vs highAnnual vs high | Annual vs lowAnnual vs low | Quarter. vs highQuarter. vs high | Quarter. vs lowQuarter. vs low | |
|---|---|---|---|---|---|
| 3 y | 3-year | -23.2% | +383.4% | -46.3% | +463.6% |
| 5 y | 5-year | -23.2% | +383.4% | -46.3% | +463.6% |
| alltime | all time | -23.2% | +1221.2% | -46.3% | +843.8% |
Trevi Therapeutics Shareholders Equity History
| Date | Annual | Quarterly |
|---|---|---|
| Sep 2024 | - | $58.97 M(-10.9%) |
| Jun 2024 | - | $66.17 M(-8.5%) |
| Mar 2024 | - | $72.33 M(-12.4%) |
| Dec 2023 | $82.55 M(-23.2%) | $82.55 M(-7.9%) |
| Sep 2023 | - | $89.61 M(-5.7%) |
| Jun 2023 | - | $95.07 M(-6.5%) |
| Mar 2023 | - | $101.73 M(-5.3%) |
| Dec 2022 | $107.46 M(+529.3%) | $107.46 M(-2.2%) |
| Sep 2022 | - | $109.90 M(+81.6%) |
| Jun 2022 | - | $60.52 M(+478.4%) |
| Mar 2022 | - | $10.46 M(-38.7%) |
| Dec 2021 | $17.07 M | $17.07 M(+50.0%) |
| Date | Annual | Quarterly |
|---|---|---|
| Sep 2021 | - | $11.38 M(-35.8%) |
| Jun 2021 | - | $17.74 M(-25.1%) |
| Mar 2021 | - | $23.68 M(-13.2%) |
| Dec 2020 | $27.28 M(-50.0%) | $27.28 M(-23.4%) |
| Sep 2020 | - | $35.62 M(-11.0%) |
| Jun 2020 | - | $40.04 M(-14.5%) |
| Mar 2020 | - | $46.80 M(-14.2%) |
| Dec 2019 | $54.55 M(+773.0%) | $54.55 M(-10.2%) |
| Sep 2019 | - | $60.71 M(-10.3%) |
| Jun 2019 | - | $67.70 M(+434.1%) |
| Mar 2019 | - | $12.68 M(+102.9%) |
| Dec 2018 | $6.25 M(-57.7%) | $6.25 M |
| Dec 2017 | $14.78 M | - |
FAQ
- What is Trevi Therapeutics annual stockholders equity?
- What is the all time high annual shareholders equity for Trevi Therapeutics?
- What is Trevi Therapeutics annual shareholders equity year-on-year change?
- What is Trevi Therapeutics quarterly stockholders equity?
- What is the all time high quarterly shareholders equity for Trevi Therapeutics?
- What is Trevi Therapeutics quarterly shareholders equity year-on-year change?
What is Trevi Therapeutics annual stockholders equity?
The current annual shareholders equity of TRVI is $82.55 M
What is the all time high annual shareholders equity for Trevi Therapeutics?
Trevi Therapeutics all-time high annual stockholders equity is $107.46 M
What is Trevi Therapeutics annual shareholders equity year-on-year change?
Over the past year, TRVI annual stockholders equity has changed by -$24.91 M (-23.18%)
What is Trevi Therapeutics quarterly stockholders equity?
The current quarterly shareholders equity of TRVI is $58.97 M
What is the all time high quarterly shareholders equity for Trevi Therapeutics?
Trevi Therapeutics all-time high quarterly stockholders equity is $109.90 M
What is Trevi Therapeutics quarterly shareholders equity year-on-year change?
Over the past year, TRVI quarterly stockholders equity has changed by -$23.58 M (-28.56%)